Abiopharma

EVA LIVE INC (GOAI) Reports the reporting period Financial Results EVA LIVE INC (GOAI) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: $17,037,328,
• Net Income: $8,127,313,
• EPS: Not disclosed
• Cash and equivalents: Not disclosed
  • targeting and segmentation ● Creative generation and iteration ● Fraud detection and traffic quality filtering ● Continuous performance learning and model retraining The system operates on a proprietary AI architecture internally referred to as the “Eva Brain stack,” which leverages large-scale data ingestion, reinforcement learning, and predictive modeling to optimize campaign outcomes dynamically. Performance at Machine Scale According to internal benchmarks, Eva Brain has demonstrated: ● Up to 40% improvement in return on ad spend (ROAS) compared to human-managed campaigns ● Faster optimization cycles driven by real-time data processing ● The ability to manage and scale campaigns simultaneously across multiple platforms without human latency “Marketing has historically been limited by human bandwidth, fragmented tools, and delayed feedback loops,” said David Boulette, Chief Executive Officer of Eva Live Inc. “Eva Brain removes those constraints. It is designed to operate continuously, learn from every interaction, and make decisions at a speed and scale no human team can match.” Backed by Strong Financial Momentum The launch of Eva Brain follows a year of significant financial growth for Eva Live Inc. For the year ended December 31, 2025